2,323 results match your criteria: "Abortion Incomplete"
Laeknabladid
January 2025
Faculty of Medicine, School of Health Sciences, University of Iceland, Department of Obstetrics and Gynecology, Landspitali- The National University Hospital, Iceland.
Introduction: Medical treatment for termination of pregnancy in the first trimester of pregnancy was first introduced in 2006 at Landspitali. This new method, which replaced surgery, slowly gained ground and now most abortions in Iceland are medically induced. It is therefore appropriate to evaluate the effectiveness and safety of this method.
View Article and Find Full Text PDFReprod Health
December 2024
School of Health and Welfare, Dalarna University, Högskolegatan 2, 79188, Falun, Sweden.
Background: In Iran, restrictive abortion laws have led to widespread unsafe abortions, posing significant health risks. The 2021 Family and Youth Protection Law further restricted access to reproductive health services in an effort to boost birth rates. The purpose of this qualitative study is to explore the reasons women sought abortions in an illegal context, based on their own experiences.
View Article and Find Full Text PDFEur J Contracept Reprod Health Care
December 2024
Etlik Zübeyde Hanım Women Health Education and Research Hospital, University of Medical Sciences, Etlik, Ankara, Turkey.
Purpose: The aim of this retrospective cohort study was to investigate the effects of hysteroscopic uterine septum resection on the clinical pregnancy rate (CPR), live birth rate (LBR) and miscarriage rate.
Materials And Method(s): Hospital records of consecutive patients who underwent hysteroscopic uterine septum resection between February 2021 and December 2022 were reviewed. They were telephoned and interviewed about their reproductive performance after surgery, and pregnancy outcomes, if achieved.
Gynecol Endocrinol
December 2024
Department of gynaecology and obstetrics, Women and Children's Hospital. School of Medicine, Xiamen University, Xiamen, Fujian Province, P.R. China.
Purpose: This study aimed to compare the efficacies of Femoston and Dydrogesterone therapy in patients with incomplete abortions.
Methods: Patients with incomplete abortions were included if they preferred medication over surgical intervention. The participants were categorized into three groups: the Femoston group received Femoston, the Dydrogesterone group was administered Dydrogesterone, and the control group was followed up without treatment.
J Ethnopharmacol
January 2025
Department of Pharmacology, Anhui University of Chinese Medicine, Hefei, 230012, PR China.
Gynecol Oncol Rep
December 2024
Duke University Hospital, DUMC 3079, Durham, NC 27710, United States.
N Engl J Med
November 2024
From the Department of Women's and Children's Health, Division of Obstetrics and Gynecology (K.B., K.G.-D.), and the Department of Clinical Sciences at Danderyd Hospital (H.K.K.), Karolinska Institutet, and the Department of Obstetrics and Gynecology, Karolinska University Hospital (K.G.-D.), Stockholm, Södertälje Hospital, Södertälje (K.B.), the Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg (T.J.-A., H.H.), the Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö (P.T.), the Department of Clinical Sciences, Lund University Faculty of Medicine, Lund (P.T.), the Department of Clinical Sciences, Obstetrics, and Gynecology, Umeå University, Umeå (M.B.), and Statisticon, Uppsala (J.B.) - all in Sweden; the Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, and Chalmers Centre, NHS Lothian - both in Edinburgh (J.R.-W., S.C.); the Departments of Obstetrics and Gynecology (F.G., J.K., O.H.) and General Practice and Primary Health Care (F.G.), University of Helsinki and Helsinki University Hospital, Helsinki, and the Division of Health and Social Services, Wellbeing Services County of Vantaa and Kerava, Vantaa (F.G.) - both in Finland; the Center for Research on Environment, Health, and Population Activities, Kathmandu (A.T.), and KIST Medical College Teaching Hospital, Lalitpur (H.T.) - both in Nepal; Family Planning Australia, Sydney Medical School, University of Sydney, and the School of Public Health, University of Technology Sydney - all in Sydney (C.B.); Women's Health, Auckland City Hospital, Auckland, New Zealand (K.S., G.G.); the Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway (M.L.); and the Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre (M.M.K.), and the Hospital of Southern Jutland, Aabenraa (E.K.) - both in Denmark.
J Ethnopharmacol
January 2025
NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, 200032, China. Electronic address:
Am J Physiol Cell Physiol
October 2024
Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Radiol Case Rep
January 2025
National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
Eur J Contracept Reprod Health Care
December 2024
Department of Obstetrics & Gynaecology, Whipps Cross University Hospital, London, United Kingdom.
J Int Med Res
October 2024
Department of Obstetrics and Gynecology, Ningbo Women and Children's Hospital, Ningbo, China.
Dig Dis Sci
October 2024
Division of Gastroenterology and Hepatology, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, 35205, USA.
J Curr Ophthalmol
August 2024
Manhattan Eye, Ear and Throat Hospital, New York, New York, USA.
Afr J Prim Health Care Fam Med
August 2024
Department of Family and Emergency Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch.
Acta Obstet Gynecol Scand
December 2024
Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
SAGE Open Med
July 2024
Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
Radiol Case Rep
September 2024
Department of Radio Diagnosis and Imaging, Shree Birendra Hospital, NAIHS, Kathmandu, Nepal.
Reprod Health
July 2024
SA MRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Private Bag X3, Wits, Johannesburg, 2050, South Africa.
J Obstet Gynaecol Can
September 2024
Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON; Department of Obstetrics and Gynecology, North York General Hospital, Toronto, ON.
Hum Reprod
September 2024
Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU I3), Hôpital Saint Antoine, Sorbonne Université AP-HP, Paris, France.
Am J Reprod Immunol
June 2024
Laboratory for Reproductive Immunology, Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai Medical College, Shanghai, China.
Sci Rep
June 2024
Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavska 20, 625 00, Brno, Czech Republic.